Jane J. Zara

Array ( [id] => 1501543 [patent_doc_number] => 06486305 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'METHOD OF MODULATING THE EFFICIENCY OF TRANSLATION TERMINATION AND DEGRADATION OF ABERRANT MRNA INVOLVING A SURVEILLANCE COMPLEX COMPRISING HUMAN UPF1P, EUCARYOTIC RELEASE FACTOR 1 AND EUCARYOTIC RELEASE FACTOR 3' [patent_app_type] => B1 [patent_app_number] => 09/639987 [patent_app_country] => US [patent_app_date] => 2000-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26350 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486305.pdf [firstpage_image] =>[orig_patent_app_number] => 09639987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600917 [patent_doc_number] => 06476000 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides' [patent_app_type] => B1 [patent_app_number] => 09/639250 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5299 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476000.pdf [firstpage_image] =>[orig_patent_app_number] => 09639250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017856 [patent_doc_number] => 06890750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Composition and methods utilizing stable reporter cell lines for detection of chop-dependent signal transduction' [patent_app_type] => utility [patent_app_number] => 09/637550 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14768 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890750.pdf [firstpage_image] =>[orig_patent_app_number] => 09637550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4310610 [patent_doc_number] => 06242194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Acid-inducible promoters for gene expression' [patent_app_type] => 1 [patent_app_number] => 9/637968 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8461 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242194.pdf [firstpage_image] =>[orig_patent_app_number] => 637968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096758 [patent_doc_number] => 06822086 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Drug-carrier complexes and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/634320 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 14688 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/822/06822086.pdf [firstpage_image] =>[orig_patent_app_number] => 09634320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636724 [patent_doc_number] => 06379931 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Chimeric DNA/RNA ribozymes containing propanediol' [patent_app_type] => B1 [patent_app_number] => 09/634918 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3227 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379931.pdf [firstpage_image] =>[orig_patent_app_number] => 09634918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380227 [patent_doc_number] => 06277640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Antisense modulation of Her-3 expression' [patent_app_type] => 1 [patent_app_number] => 9/630706 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32726 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277640.pdf [firstpage_image] =>[orig_patent_app_number] => 630706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325103 [patent_doc_number] => 06602857 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => B1 [patent_app_number] => 09/629644 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32818 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602857.pdf [firstpage_image] =>[orig_patent_app_number] => 09629644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643732 [patent_doc_number] => 06429308 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'HIV infection inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/582224 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3376 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429308.pdf [firstpage_image] =>[orig_patent_app_number] => 09582224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065673 [patent_doc_number] => 06846799 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Preventing airway mucus production by administration of EGF-R antagonists' [patent_app_type] => utility [patent_app_number] => 09/616223 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 33322 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846799.pdf [firstpage_image] =>[orig_patent_app_number] => 09616223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422337 [patent_doc_number] => 06506896 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside' [patent_app_type] => B1 [patent_app_number] => 09/509039 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 18050 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506896.pdf [firstpage_image] =>[orig_patent_app_number] => 09509039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 493250 [patent_doc_number] => 07211436 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-01 [patent_title] => 'Compositions and methods for regulating abscisic acid-induced closure of plant stomata' [patent_app_type] => utility [patent_app_number] => 09/606736 [patent_app_country] => US [patent_app_date] => 2000-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14156 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211436.pdf [firstpage_image] =>[orig_patent_app_number] => 09606736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 503868 [patent_doc_number] => 07202025 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-04-10 [patent_title] => 'Control of gene expression' [patent_app_type] => utility [patent_app_number] => 10/019520 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 13664 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202025.pdf [firstpage_image] =>[orig_patent_app_number] => 10019520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1047009 [patent_doc_number] => 06864405 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Transgenic plants that exhibit enhanced nitrogen assimilation' [patent_app_type] => utility [patent_app_number] => 09/605521 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 0 [patent_no_of_words] => 22618 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864405.pdf [firstpage_image] =>[orig_patent_app_number] => 09605521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365650 [patent_doc_number] => 06566104 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'ERbB-4 targeted ribozymes' [patent_app_type] => B1 [patent_app_number] => 09/530224 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 12941 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566104.pdf [firstpage_image] =>[orig_patent_app_number] => 09530224 [rel_patent_id] =>[rel_patent_doc_number] =>)